Proposed approval of peforelin and registration of the product Maprelin

This consultation closed on 6 September 2016

Consultation period

9 August 2016 to 6 September 2016

The APVMA is considering an application for the approval of peforelin and registration of Maprelin. The product is to be used for induction of the oestrous cycle in sows after weaning, and for induction of oestrus in sexually mature gilts following therapy to inhibit the oestrous cycle with progestogens.

We invite comment from 9 August 2016 to 6 September 2016 on whether the application for approval of the active constituent and/or registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • safety criteria
  • efficacy criteria
  • trade criteria.

Download the Public Release Summary on the evaluation of the new active constituent peforelin in the product Maprelin.

For more information see APVMA Gazette notice (page 13) from 9 August 2016

Please send your written submission by email, post or fax to:

Registration Management and Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604


Fax: +61 2 6210 4721
Phone: +61 2 6210 4701

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.